Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3958
Source ID: NCT00527995
Associated Drug: Sildenafil
Title: Acute Effects of Sildenafil on Endothelial Function in People With Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Endothelial Dysfunction
Interventions: DRUG: Sildenafil
Outcome Measures: Primary: Improvement of flow mediated dilatation of the brachial artery following a single dose of 100mg Sildenafil., 60 minutes | Secondary: Change in hemodynamics and cardiovascular parasympathetic and sympathetic nerve function using time domain and frequency domain indexes of heart rate variability (HRV) and baroreflex sensitivity (BRS) following a single dose of 100mg Sildenafil., 60 minutes
Sponsor/Collaborators: Sponsor: Ruhr University of Bochum
Gender: MALE
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 40
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2001-08
Completion Date: 2003-06
Results First Posted:
Last Update Posted: 2007-09-11
Locations: German Diabetes Center, Duesseldorf, North Rhine-Westphalia, 40225, Germany
URL: https://clinicaltrials.gov/show/NCT00527995